LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Search

Myomo Inc

Fechado

0.82 3.8

Visão Geral

Variação de preço das ações

24h

Atual

Mín

0.76

Máximo

0.82

Indicadores-chave

By Trading Economics

Rendimento

-1.2M

-4.6M

Vendas

438K

10M

Margem de lucro

-47.989

Funcionários

184

EBITDA

644K

-3.5M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+664.71% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.9M

35M

Abertura anterior

-2.98

Fecho anterior

0.82

Myomo Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de nov. de 2025, 21:34 UTC

Ganhos

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13 de nov. de 2025, 23:45 UTC

Conversa de Mercado

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13 de nov. de 2025, 23:42 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13 de nov. de 2025, 23:41 UTC

Conversa de Mercado

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13 de nov. de 2025, 23:24 UTC

Ganhos

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13 de nov. de 2025, 23:24 UTC

Ganhos

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13 de nov. de 2025, 23:23 UTC

Ganhos

JBS NV 3Q EPS 52c >JBS

13 de nov. de 2025, 23:23 UTC

Ganhos

JBS NV 3Q Sales $22.6B >JBS

13 de nov. de 2025, 23:04 UTC

Conversa de Mercado

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13 de nov. de 2025, 22:02 UTC

Ganhos

Nu Holdings 3Q Net $783M >NU

13 de nov. de 2025, 22:01 UTC

Ganhos

Nu Holdings 3Q Rev $4.2B >NU

13 de nov. de 2025, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13 de nov. de 2025, 21:50 UTC

Ganhos

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13 de nov. de 2025, 21:45 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13 de nov. de 2025, 21:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13 de nov. de 2025, 21:36 UTC

Aquisições, Fusões, Aquisições de Empresas

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13 de nov. de 2025, 21:33 UTC

Conversa de Mercado

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13 de nov. de 2025, 21:33 UTC

Ganhos

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13 de nov. de 2025, 21:31 UTC

Ganhos

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13 de nov. de 2025, 21:25 UTC

Ganhos

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13 de nov. de 2025, 21:25 UTC

Ganhos

Figure Tech Solutions 3Q EPS 34c >FIGR

13 de nov. de 2025, 21:23 UTC

Ganhos

Intchains Group 3Q Rev $1.3M >ICG

13 de nov. de 2025, 21:03 UTC

Ganhos

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13 de nov. de 2025, 21:02 UTC

Ganhos

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13 de nov. de 2025, 21:01 UTC

Ganhos

Applied Materials 4Q Rev $6.8B >AMAT

13 de nov. de 2025, 21:01 UTC

Ganhos

Applied Materials 4Q Gross Margin 48.0% >AMAT

Comparação entre Pares

Variação de preço

Myomo Inc Previsão

Preço-alvo

By TipRanks

664.71% parte superior

Previsão para 12 meses

Média 6.5 USD  664.71%

Máximo 10.5 USD

Mínimo 4 USD

Com base em 4 analistas de Wall Street que oferecem metas de preço de 12 meses para Myomo Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

4 ratings

4

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
help-icon Live chat